NSE filing, NSE: SANGANI. Summary written from the filing by ALFA Finder's alert engine.
Sangani Hospitals Ltd: key numbers
- Share price
- ₹62.65
- Market cap
- ₹86.31 Cr
- Revenue (annual)
- ₹107.0 Cr
- Net profit (annual)
- ₹2.99 Cr
- P/E (TTM)
- 28.9×Sector 34.1×
- Promoter holding
- 74.09%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sangani Hospitals Ltd
All →Sangani Hospitals Management Change
Sangani Hospitals Limited has appointed M/s. R G G R & Associates LLP as Statutory Auditors. The appointment is for a five-year term effective September 28, 2026.
- Execution
- 60 months
Sangani Hospitals Annual General Meeting
Sangani Hospitals Limited held its 5th Annual General Meeting on September 28, 2026, to discuss financial statements, director re-appointment, and statutory auditor appointment.
Sangani Hospitals Other Announcement
Sangani Hospitals Limited appointed M/s. R G G R & Associates LLP as the company's new statutory auditor, effective September 3, 2026.
Sangani Hospitals Annual General Meeting
Sangani Hospitals Limited will hold its Fifth Annual General Meeting on September 28, 2026. The meeting will address financial statements, director reappointment, and statutory auditor appointment.
Sangani Hospitals Board Meeting Outcome
Sangani Hospitals approved its board report, the statutory auditor appointment, and the notice for the fifth annual general meeting to be held on September 28, 2026.
Sangani Hospitals Board Meeting Date
Sangani Hospitals Limited has scheduled a board meeting for September 3, 2026. The agenda includes approval of the board report and AGM-related business.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.